July 21, 2020; 2:00 pm – 3:00 pm ET
Metabolic Diseases (Prediabetes, Diabetes, NASH, Clinical Obesity) affect over 50% of the US population. Traditional approaches to care including pharmacology, general nutrition, and lifestyle and exercise have not created sustainable or effective solutions. Each year, more and more employees develop both prediabetes and diabetes, and most diabetes-related programs are failing to attract significant enrollees while suffering from poor engagement.
After 10 years of scientific research a novel approach to sustainable prediabetes and diabetes remission based on gut-microbiome profiling has emerged—DayTwo’s Food as Medicine Diabetes Remission™ solution. The science has validated that people respond differently to the same food, and so their diet must be precise and individualized according to their unique biology. In the current pandemic, where routines are being disrupted and isolation increases risk factors, precision nutrition that meets patient members where they form an eating experience perspective, is an extraordinarily effective way to attract and engage patient members and drive metabolic disease and its rising costs into remission. In this webinar,
This webinar is co-hosted by World Congress and Validation Institute.
Jan is a tri-sector healthcare executive with over 30 years of experience with CVS Health, Mid-West Business Group on Heath, and Health Intelligence Partners.
Melinda D. Maryniuk, MEd, RD, CDE, FADA
Melinda is an award-winning diabetes educator with over 35 years of experience at Joslin Diabetes Center.
Alan is a healthcare leader with over 30 years of experience with Blue Cross Blue Shield, Accolade, Anthem and Willis Towers Watson.
DayTwo uses Food As Medicine to enable a path to remission for Type 2 diabetes and PreDiabetes. People respond very differently to the same food, therefore, knowing what food and what combination of foods “works” for each person is crucial to an effective Diabetes care plan.
DayTwo uses a gut profile (stool sample, akin to Cologuard) to identify the right food and nutrition plan for each patient, to balance blood sugar levels, improve energy, manage hunger, and lose weight.
The DayTwo solution is delivered through registered dietitians, diabetes educators, and doctors via tele-health (text, video, and phone) a gut profile lab test, and a mobile app to track progress and improvement and communicate with the members assigned clinician-coach.
DayTwo uses A1C and Time In Range as the primary clinical outcomes, and weight as a secondary outcome. For those employers who implement the DayTwo protocol, DayTwo offers up to 100% fees-at-risk.